Quantitative performance of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Andrew J Fratoni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Pseudomonas aeruginosa, Anti-Bacterial Agents, Tobramycin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Global Antimicrobial Resistance Innovation Fund, UK Department of Health and Social Care, Administration for Strategic Preparedness and Response.
Abstract (Originalsprache)
Background
The COMBINE murine neutropenic pneumonia model looks to standardize an important element of preclinical development and provide interlaboratory uniformity. Herein we provide quantitative bacterial density in lung benchmark efficacy data of humanized exposures of meropenem, cefiderocol and tobramycin in plasma and epithelial lining fluid (ELF) against a collection of Klebsiella pneumoniae and Pseudomonas aeruginosa.
Methods
In accordance with the COMBINE protocol, human-simulated regimens (HSRs) based on both plasma and ELF exposures of meropenem, cefiderocol (both as 2 g q8h as 3 h infusions) and tobramycin 7 mg/kg as 30 min infusions were tested against K. pneumoniae and P. aeruginosa isolates. The 24 h change in cfu/lung for each HSR was calculated. Each isolate was tested in duplicate against both the plasma and ELF HSRs on separate experiment days.
Results
Meropenem HSRs demonstrated >1 log10 kill against all P. aeruginosa isolates with MICs of ≤16 mg/L, but only against K. pneumoniae isolates with MICs of ≤2 mg/L as isolates with MICs of >2 mg/L generally harboured carbapenemases. Cefiderocol HSRs uniformly achieved >1 log10 kill against both species at MICs of ≤8 mg/L, with net growth and extensive variability in P. aeruginosa isolates with MICs of 16 mg/L. All tobramycin-susceptible isolates demonstrated >1 log10 kill, while non-susceptible isolates did not. Differences in cfu/lung magnitude between the plasma and ELF HSRs were most pronounced around the clinical breakpoints.
Conclusions
In the COMBINE pneumonia model, administration of plasma and ELF HSRs of meropenem, cefiderocol and tobramycin demonstrated 24 h cfu/lung within reason of expectation given known PK/PD properties and existing clinical breakpoints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.
- CARB-X, Boston, MA, USA.
ORCID-Profile: David P Nicolau
Förderung
- Global Antimicrobial Resistance Innovation Fund
- UK Department of Health and Social Care
- Administration for Strategic Preparedness and Response
- U.S. Department of Health and Human Services
- Wellcome
- Wellcome Trust
- NIEHS NIH HHS
- Biomedical Advanced Research and Development Authority
Zitieren
APA
Fratoni, A. J., Padgett, A. M., Duffy, E. M., & Nicolau, D. P. (2025). Quantitative performance of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf100
Vancouver
Fratoni AJ, Padgett AM, Duffy EM, Nicolau DP. Quantitative performance of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf100
BibTeX
@article{Fratoni2025,
author = {Fratoni, Andrew J and Padgett, Alissa M and Duffy, Erin M and Nicolau, David P},
title = {Quantitative performance of humanized plasma and epithelial lining fluid exposures of meropenem, cefiderocol and tobramycin against a challenge set of Klebsiella pneumoniae and Pseudomonas aeruginosa in a standardized neutropenic murine pneumonia model},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf100}
}
EUVIMED